Bio-MOFs Based on Natural Phenolic, Hematoxylin Leverages Biomedical Applications: Enzyme Inhibition, Antioxidant, and Antibacterial Properties
dc.authorid | Şahiner, Mehtap / 0000-0001-8666-7954 | |
dc.authorid | Demirci, Şahin / 0000-0001-7083-1481 | |
dc.authorid | Şahiner, Nurettin / 0000-0003-0120-530X | |
dc.contributor.author | Şahiner, Mehtap | |
dc.contributor.author | Tian, Zhi | |
dc.contributor.author | Demirci, Şahin | |
dc.contributor.author | Sunol, Aydın | |
dc.contributor.author | Allen-Gipson, Diane S. | |
dc.contributor.author | Şahiner, Nurettin | |
dc.date.accessioned | 2025-01-27T20:45:28Z | |
dc.date.available | 2025-01-27T20:45:28Z | |
dc.date.issued | 2024 | |
dc.department | Çanakkale Onsekiz Mart Üniversitesi | |
dc.description.abstract | Here, using natural hematoxylin (HT) as linker, metal-organic frameworks (MOFs) from Cu(II), Fe(II), and Fe(III) ions was prepared. The SEM images and DLS analyses revealed HT-based MOFs are <micrometer sizes with the highest surface area value of 49.2 m2/g for HT−Fe(III) MOFs. Interestingly, HT-based MOFs exhibit fluorescent properties at λem=330 nm with fluorescence intensities of 11485, 2120, and 6790 (a.u) for HT−Cu(II), Fe(II), and Fe(III) MOFs, respectively. Moreover, HT-based MOFs inhibited α-glucosidase enyzme in a concentration-dependent manner e. g., 33.1 %, 69.8 %, and 59.7 % of Cenzyme=500 mg/mL was inhibited by HT−Cu(II)-MOF, HT−Fe(II)-MOF, and HT−Fe(III)-MOFs, respectively. The minimum bactericidal concentration (MBC) values of HT−Cu(II) MOFs for Escherichia coli (gram −), Staphylococcus aureus (gram +), and Candida albicans are determined as 5, 5, and 10 mg/mL, respectively. Also, the antioxidant activities of 250 ppm HT-based MOF based on total phenol content (TPC) tests revealed 279, 208, 124, and 152 mg.gallic acid equivalent/mL (mg GA equivalency/mL) for HT, HT−Cu(II) MOF, HT−Fe(II) MOF, and HT−Fe(III), respectively affirming that antioxidant properties were retained. Moreover, HT−Fe(II) and HT−Fe(III) MOFs (62.5 μg/mL) against human null-1 lung cell line revealed cell viabilities of 98.7±12.2 % and 88.9±11.7 %, respectively as concentration-dependent biocompatibility of MOFs. | |
dc.description.sponsorship | BIdot;DEB-2219 Postdoctoral Research Program [1059B192201458]; Scientific and Technological Research Council of Turkey (TUBITAK) | |
dc.description.sponsorship | The B & Idot;DEB-2219 Postdoctoral Research Program, 1059B192201458, of the Scientific and Technological Research Council of Turkey (TUBITAK) provided funding for this study. | |
dc.identifier.doi | 10.1002/cbdv.202401857 | |
dc.identifier.issn | 1612-1872 | |
dc.identifier.issn | 1612-1880 | |
dc.identifier.pmid | 39327818 | |
dc.identifier.scopus | 2-s2.0-85208202473 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.uri | https://doi.org/10.1002/cbdv.202401857 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12428/24586 | |
dc.identifier.wos | WOS:001357314500001 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Wiley-V C H Verlag Gmbh | |
dc.relation.ispartof | Chemistry & Biodiversity | |
dc.relation.publicationcategory | info:eu-repo/semantics/openAccess | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.snmz | KA_WoS_20250125 | |
dc.subject | Phenolic Metal-Organic Frameworks | |
dc.subject | Hematoxylin | |
dc.subject | Antimicrobial/antioxidant MOFs | |
dc.subject | Biocompatible MOFs | |
dc.subject | Alpha-glucosidase inhibitors | |
dc.title | Bio-MOFs Based on Natural Phenolic, Hematoxylin Leverages Biomedical Applications: Enzyme Inhibition, Antioxidant, and Antibacterial Properties | |
dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1